Literature DB >> 12637080

Comparison of the effects of acute influenza infection and Influenza vaccination on HIV viral load and CD4 cell counts.

Daniel J Skiest1, Timothy Machala.   

Abstract

PURPOSE: Influenza vaccination is recommended for HIV-infected patients, although the efficacy is not clear. Prior studies have yielded differing results with regard to the effects of influenza vaccination on HIV viral load and CD4 cell counts. The effects of acute influenza on HIV viral replication and CD4 cell counts have not been well described. We sought to assess the effect of influenza infection and vaccination on HIV viral load and CD4 cell counts. SUBJECTS AND METHODS: All cases of influenza occurring in HIV-infected individuals over 3 years at a large county hospital were reviewed. For the year 1997-1998, data on all HIV clinic patients who were vaccinated for influenza were recorded prospectively. In order to assess the effects of influenza infection (Group I) and vaccination (Group II) on HIV viral load and CD4 cell counts, values from before and after influenza infection or vaccination were compared to each other and to a matched control group not vaccinated and without influenza infection (Group III).
RESULTS: Forty-three cases of influenza were diagnosed. Pre- and post-influenza viral load in Group I was not significantly different: 3.34 versus 3.49 log copies/ml (P=0.36). Viral load was unchanged in 22 of 37 patients, increased in ten patients and decreased in five patients. Similarly, pre- and post-vaccination viral load in Group II was not significantly different: 3.52 versus 3.66 log copies/ml (P=0.12). Thirty-four of 47 patients who received influenza vaccine had no significant change in viral load-viral load increased in ten patients and decreased in three patients. No significant CD4 cell count changes were noted following influenza infection or vaccination. In contrast, Group III patients experienced a small decline in viral load from 4.23 to 3.39 log copies/ml, P<0.05, while there was a trend towards an increase in CD4 cell counts (P=0.06).
CONCLUSIONS: Following influenza infection or vaccination, most patients did not have a significant increase in HIV viral load or decrease in CD4 cell count.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637080     DOI: 10.1016/s1386-6532(02)00047-1

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  9 in total

Review 1.  Immunization of HIV-infected adult patients - French recommendations.

Authors:  Anne Frésard; Amandine Gagneux-Brunon; Frédéric Lucht; Elisabeth Botelho-Nevers; Odile Launay
Journal:  Hum Vaccin Immunother       Date:  2016-07-13       Impact factor: 3.452

2.  Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial.

Authors:  Odile Launay; Corinne Desaint; Christine Durier; Pierre Loulergue; Xavier Duval; Christine Jacomet; Gilles Pialoux; Jade Ghosn; François Raffi; David Rey; Faiza Ajana; Nathalie Colin de Verdière; Jacques Reynes; Valérie Foubert; François Roman; Jeanne-Marie Devaster; Jean-François Delfraissy; Jean-Pierre Aboulker
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

3.  Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Lynn E Eberly; Chris Duplessis; Jason Maguire; Anuradha Ganesan; Dennis Faix; Gabriel Defang; Yun Bai; Erik Iverson; Tahaniyat Lalani; Timothy Whitman; Patrick J Blair; Carolyn Brandt; Grace Macalino; Timothy Burgess
Journal:  Clin Infect Dis       Date:  2010-12-07       Impact factor: 9.079

4.  Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.

Authors:  P Durando; D Fenoglio; A Boschini; F Ansaldi; G Icardi; L Sticchi; A Renzoni; P Fabbri; A Ferrera; A Parodi; B Bruzzone; G Gabutti; A Podda; G Del Giudice; E Fragapane; F Indiveri; P Crovari; R Gasparini
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

5.  Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis.

Authors:  Julius Atashili; Linda Kalilani; Adaora A Adimora
Journal:  BMC Infect Dis       Date:  2006-09-11       Impact factor: 3.090

Review 6.  Influenza vaccination in HIV-positive subjects: latest evidence and future perspective.

Authors:  A Ceravolo; A Orsi; V Parodi; F Ansaldi
Journal:  J Prev Med Hyg       Date:  2013-03

7.  H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir.

Authors:  Thor A Wagner; Hannah C Huang; Christen E Salyer; Kelly M Richardson; Adriana Weinberg; Sharon Nachman; Lisa M Frenkel
Journal:  AIDS Res Ther       Date:  2017-02-13       Impact factor: 2.250

8.  COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity.

Authors:  Ying Liu; Junyan Han; Xin Li; Danying Chen; Xuesen Zhao; Yaruo Qiu; Leidan Zhang; Jing Xiao; Bei Li; Hongxin Zhao
Journal:  Vaccines (Basel)       Date:  2021-12-09

9.  HIV virological suppression influences response to the AS03-adjuvanted monovalent pandemic influenza A H1N1 vaccine in HIV-infected children.

Authors:  Timothy R Leahy; Michelle Goode; Paul Lynam; Patrick J Gavin; Karina M Butler
Journal:  Influenza Other Respir Viruses       Date:  2014-02-18       Impact factor: 4.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.